A Clinical Framework for Assessing Cannabis-Related Impairment Risk
Abstract Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use…
Abstract Clinicians play an important role in promoting safe and responsible medical cannabis use. One essential component to safe use…
Abstract The nonpsychoactive cannabinoid, cannabidiol (CBD), is Food and Dug Administration approved for treatment of two drug-resistant epileptic disorders and…
Abstract Cannabis sativa L. is a plant belonging to the Cannabaceae family, cultivated for its psychoactive cannabinoid (Δ9-THC) concentration or…
Abstract Accumulating data from both human and animal studies suggest that cannabidiol (CBD) may be associated with improved cardiovascular function,…
Abstract Δ9-Tetrahydrocannabinol is the main psychoactive component of cannabis and cannabidiol is purportedly responsible for many of the medicinal benefits.…
Abstract Plant-derived phytochemicals have gifted humans with vast therapeutic potentials. Yet, the unique features of the blood–brain barrier significantly limit…
Abstract Background: Nabiximols is a cannabis-based drug to treat spasticity-associated symptoms currently approved for patients with multiple sclerosis only. Cannabinoids…
Abstract The aim of this study was to propagate axillary shoots of Cannabis sativa L. using liquid medium in temporary…
Abstract The use of Δ8THC is increasing at present across the USA in association with widespread cannabis legalization and the…
Abstract Background: The prevalence of cannabis use and cannabis use disorders (CUD) has significantly increased over time. However, there are…